Skip to main content
. 2013 May;98(5):722–728. doi: 10.3324/haematol.2012.076901

Figure 1.

Figure 1.

Overall survival according to the presence or absence of the risk factor JAK2 p.V617F allele burden >1% at day 28 after allogeneic SCT: 15 patients were grouped in the low-risk arm (continuous line), 15 patients in the high-risk arm (dashed line).